Petersdorf Nicholas, Ross Jennifer M, Weiss Helen A, Barnabas Ruanne V, Wasserheit Judith N
London School of Economics, University of London, London, UK.
Division of Infectious Diseases, University of Washington, Seattle, WA, USA;
J Int AIDS Soc. 2016 Sep 19;19(1):20944. doi: 10.7448/IAS.19.1.20944. eCollection 2016.
Hepatitis C virus (HCV) and HIV infection frequently co-occur due to shared transmission routes. Co-infection is associated with higher HCV viral load (VL), but less is known about the effect of HCV infection on HIV VL and risk of onward transmission.
We undertook a systematic review comparing 1) HIV VL among ART-naïve, HCV co-infected individuals versus HIV mono-infected individuals and 2) HIV VL among treated versus untreated HCV co-infected individuals. We performed a random-effects meta-analysis and quantified heterogeneity using the I(2) statistic. We followed Cochrane Collaboration guidelines in conducting our review and PRISMA guidelines in reporting results.
We screened 3925 articles and identified 17 relevant publications. A meta-analysis found no evidence of increased HIV VL associated with HCV co-infection or between HIV VL and HCV treatment with pegylated interferon-alpha-2a/b and ribavirin.
This finding is in contrast to the substantial increases in HIV VL observed with several other systemic infections. It presents opportunities to elucidate the biological pathways that underpin epidemiological synergy in HIV co-infections and may enable prediction of which co-infections are most important to epidemic control.
丙型肝炎病毒(HCV)和HIV感染因传播途径相同而经常同时发生。合并感染与更高的HCV病毒载量(VL)相关,但关于HCV感染对HIV病毒载量及后续传播风险的影响,人们了解较少。
我们进行了一项系统评价,比较1)未接受抗逆转录病毒治疗(ART)的HCV合并感染个体与HIV单一感染个体的HIV病毒载量,以及2)接受治疗与未接受治疗的HCV合并感染个体的HIV病毒载量。我们进行了随机效应荟萃分析,并使用I(2)统计量对异质性进行量化。我们遵循Cochrane协作网指南进行综述,并按照PRISMA指南报告结果。
我们筛选了3925篇文章,确定了17篇相关出版物。荟萃分析未发现证据表明HCV合并感染会增加HIV病毒载量,也未发现HIV病毒载量与聚乙二醇化干扰素-α-2a/b及利巴韦林治疗HCV之间存在关联。
这一发现与其他几种全身性感染时观察到的HIV病毒载量大幅增加形成对比。它为阐明HIV合并感染中流行病学协同作用的生物学途径提供了机会,并可能有助于预测哪些合并感染对疫情控制最为重要。